Meril Diagnostics Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Meril Diagnostics Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $7.2M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Meril Diagnostics Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $7.2M Trade | TransData Nexus

Meril Diagnostics Private Limited

Indian Pharmaceutical Exporter · Medical Devices & Diagnostics Specialist · $7.2M Total Trade · DGFT Verified

Meril Diagnostics Private Limited is an Indian pharmaceutical exporter with a total trade value of $7.2M across 3 products in 2 therapeutic categories. Based on 813 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Kit ($5.6M), Diagnostic ($1.6M), Plasma ($30.7K).

Meril Diagnostics Private Limited — Export Portfolio & Destination Treemap

Meril Diagnostics Private Limited pharmaceutical export portfolio — 3 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Meril Diagnostics Private Limited? — Company Overview & Market Position

Meril Diagnostics Private Limited, incorporated on April 18, 2011, is a private unlisted company based in Vapi, Gujarat, India. The company specializes in the manufacture of medical devices and diagnostic products, focusing on finished pharmaceutical formulations such as tablets, capsules, syrups, and injections. Its Corporate Identification Number (CIN) is U33110GJ2011PTC064994.

The authorized share capital of Meril Diagnostics is ₹293.00 crore, with a paid-up capital of ₹292.47 crore. The company is privately held, with promoter holdings accounting for 92.83% as of the latest available data. The registered office is located at No. 135/139, Bilakhia House, Muktanand Marg, Chala, Vapi, Gujarat, India, 396191.

What Does Meril Diagnostics Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Kit$5.6M 2Diagnostic$1.6M

Product Portfolio — Top 3 by Export Value

Meril Diagnostics Private Limited exports 3 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Kit	Medical Devices & Diagnostics	$5.6M	645	1.3%	8
2	Diagnostic	Medical Devices & Diagnostics	$1.6M	161	8.5%	3
3	Plasma	Other	$30.7K	7	1.1%	10

Meril Diagnostics Private Limited exports 3 pharmaceutical products across 2 therapeutic categories with a total export value of $7.2M. The top category is Medical Devices & Diagnostics (99.6% of portfolio), followed by Other (0.4%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Meril Diagnostics Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Meril Diagnostics operates a state-of-the-art manufacturing facility in Vapi, Gujarat, India. The facility spans 300,000 square feet and is equipped with advanced technology to produce a wide range of diagnostic products. This includes analyzers and reagents for clinical biochemistry, hematology, immunology, and other diagnostic applications.

3Key Leadership

The company's leadership includes Directors Pramodkumar Minocha and Rajnikant Gandalal Vyas, both appointed on April 18, 2011. Additionally, Vishakha Kiran Sonaje serves as the Company Secretary, appointed on September 9, 2024.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Meril Diagnostics Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Meril Diagnostics has made significant strides in obtaining regulatory approvals for its products in various international markets. In March 2026, the World Health Organization (WHO) issued a Medical Product Alert concerning certain in vitro diagnostic medical devices manufactured by Meril Diagnostics Pvt. Ltd. This alert was directed to national regulatory authorities and users, including control programs and procurement agencies. (who.int)

2Emerging Markets

Meril Diagnostics has been actively expanding its presence in emerging markets, particularly in Africa, Latin America, and Southeast Asia. The company's commitment to quality and innovation has facilitated its entry into these regions, enabling access to a broader customer base. However, as of March 2026, specific details regarding WHO prequalification for Meril Diagnostics' products are not publicly available. (who.int)

3Geographic Strategy

Meril Diagnostics has adopted a strategic approach to geographic diversification, focusing on both developed and emerging markets. This strategy aims to mitigate concentration risk and leverage growth opportunities across different regions. The company's expansion into various international markets reflects its commitment to becoming a global player in the diagnostics industry.

Meril Diagnostics Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

As of March 2026, specific details regarding Meril Diagnostics' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company has not publicly disclosed information regarding its interactions with the U.S. Food and Drug Administration (FDA).

2WHO & EU GMP

In December 2025, the World Health Organization (WHO) issued a Notice of Concern (NOC) for Meril Diagnostics Pvt. Ltd., indicating potential issues with certain in vitro diagnostic medical devices manufactured by the company. This notice was published on December 19, 2025, and is accessible through the WHO Prequalification Unit's website. (extranet.who.int)

3CDSCO & Indian Regulatory

Meril Diagnostics holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority in India. The company complies with the regulatory requirements set forth by the CDSCO and state drug controllers, ensuring the safety and efficacy of its products. Additionally, Meril Diagnostics has obtained export No Objection Certificates (NOCs) from the Directorate General of Foreign Trade (DGFT), facilitating its international trade activities.

Meril Diagnostics Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Meril Diagnostics operates in a competitive landscape with several key players in the diagnostics industry. The company's focus on innovation and quality has enabled it to establish a strong presence in both domestic and international markets. While specific market share data is not publicly available, Meril Diagnostics' strategic initiatives and product offerings position it as a significant competitor in the diagnostics sector.

2Key Differentiators

Meril Diagnostics distinguishes itself through its commitment to innovation, quality, and customer-centric approach. The company's state-of-the-art manufacturing facilities and comprehensive product portfolio, including analyzers and reagents for various diagnostic applications, underscore its dedication to meeting the evolving needs of the healthcare industry.

3Strategic Position

Meril Diagnostics is strategically positioned to capitalize on the growing demand for diagnostic products globally. The company's focus on research and development, coupled with its expansion into emerging markets, reflects a strategic direction aimed at becoming a leading player in the diagnostics industry. Future outlooks suggest continued growth and innovation, with an emphasis on enhancing product offerings and market reach.

Buyer Due Diligence Brief — Evaluating Meril Diagnostics Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Meril Diagnostics has demonstrated a strong track record in manufacturing and exporting diagnostic products. The company's export volume and consistency indicate reliability in meeting international demand. However, the recent WHO Medical Product Alert in March 2026 highlights the importance of ongoing vigilance and quality assurance in maintaining supplier reliability. (who.int)

2Certifications to Verify

Importers should verify the following certifications when considering Meril Diagnostics as a supplier:

FDA Registration: Confirm the company's registration status with the U.S. Food and Drug Administration (FDA) to ensure compliance with U.S. regulations.

WHO Prequalification: Check for WHO prequalification status, which indicates adherence to international quality standards.

EU GMP Certification: Verify the company's compliance with European Union Good Manufacturing Practice (GMP) standards.

Frequently Asked Questions — Meril Diagnostics Private Limited

How many pharmaceutical products does Meril Diagnostics Private Limited export from India?

Meril Diagnostics Private Limited exports 3 pharmaceutical products across 2 therapeutic categories. The top exports are Kit ($5.6M), Diagnostic ($1.6M), Plasma ($30.7K). Total export value is $7.2M.

What is Meril Diagnostics Private Limited's total pharmaceutical export value?

Meril Diagnostics Private Limited's total pharmaceutical export value is $7.2M, based on 813 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Meril Diagnostics Private Limited cover?

Meril Diagnostics Private Limited exports across 2 therapeutic categories. The largest are Medical Devices & Diagnostics (99.6%, 2 products), Other (0.4%, 1 products).

Get Full Meril Diagnostics Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.